Maria Wigren

Company: Idogen AB

Job title: Senior Scientist & R&D Team Leader

Seminars:

Discussing a Tolerogenic Dendritic Cell Platform, Presenting the Antigen FVIII 10:00 am

Discover a novel and patented platform for generation of tolerogenic DCs Learn how tolerogenic DCs loaded with FVIII can be used to treat haemophilia A patients who developed inhibitors Hear how the tolerogenic DCs have a potential to induce both regulatory T and B cellsRead more

day: Day Two